The 2026 Speaker Bureau Benchmarks Report delivers a comprehensive, data driven view of speaker program performance across IQVIA’s portfolio, based on completed 2025 activity. It examines key trends in program mix, attendance, cost dynamics, lead times, and therapeutic area performance, highlighting the continued strength of Live programs and the evolving role of Virtual formats as scalable reach amplifiers.

With deep analysis across cardiovascular, metabolic, neurology, psychiatry, oncology, infectious disease, and the newly added respiratory therapeutic area, the report reveals a maturing and increasingly predictable engagement environment. Insights into launch patterns, cost pressures, honoraria trends, and format effectiveness equip life sciences teams with practical benchmarks to support planning, optimization, and strategic decision making.

Download the 2026 Speaker Bureau Benchmarks Report to access actionable insights that can help refine your engagement strategy, optimize program value, and confidently plan for 2026 and beyond.